Discovery of Pyrazoline Benzenesulfonamide Derivatives as Anticancer Agents: A Review
Dadang Muhammad Hasyim, Ida Musfiroh, Rudi Hendra, Ezatul Ezleen Kamarulzaman, Ritmaleni Ritmaleni, Muchtaridi Muchtaridi · 2025
Read Discovery of Pyrazoline Benzenesulfonamide Derivatives as Anticancer Agents: A Review by Dadang Muhammad Hasyim, Ida Musfiroh, Rudi Hendra, Ezatul Ezleen Kamarulzaman, Ritmaleni Ritmaleni, Muchtaridi Muchtaridi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12755108.txt.
Description
Two chemical motifs with strong track records, the pyrazoline ring and the benzenesulfonamide group, become more than the sum of their parts when fused into one molecule. Dadang Muhammad Hasyim and co-authors review this hybrid family as anticancer candidates: how they are made, which targets they hit, and how their shapes govern their strength. Synthesis routes range from a classic condensation reaction to ultrasound- and microwave-assisted shortcuts that speed diversification.
Several derivatives killed lung, breast, cervical, colon, and oral cancer cells in dishes while sparing normal cells. Docking studies tie them to tumor enzymes including two matrix metalloproteinases, two carbonic anhydrases, and COX-2. Changing the electronic character and position of ring substituents tuned both potency and selectivity. The authors argue the family deserves continued optimization against drug resistance and side effects.
Catalog record
| CREATOR | Dadang Muhammad Hasyim, Ida Musfiroh, Rudi Hendra, Ezatul Ezleen Kamarulzaman, Ritmaleni Ritmaleni, Muchtaridi Muchtaridi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 135 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |